Anonymous (2026). Outcomes in the BETAMI-DANBLOCK trial compared with a Norwegian nationwide myocardial infarction population.. European heart journal.
Anonymous. Outcomes in the BETAMI-DANBLOCK trial compared with a Norwegian nationwide myocardial infarction population.. European heart journal. 2026; PMID: 42183826
Anonymous. Outcomes in the BETAMI-DANBLOCK trial compared with a Norwegian nationwide myocardial infarction population.[J]. European heart journal. 2026.
@article{paper2026,
author = {Anonymous},
title = {Outcomes in the BETAMI-DANBLOCK trial compared with a Norwegian nationwide myocardial infarction population.},
journal = {European heart journal},
year = {2026},
note = {PMID: 42183826},
}
TY - JOUR AU - Anonymous TI - Outcomes in the BETAMI-DANBLOCK trial compared with a Norwegian nationwide myocardial infarction population. T2 - European heart journal PY - 2026 AN - PMID:42183826 ER -
In patients with myocardial infarction (MI), no heart failure, and left ventricular ejection fraction (LVEF) ≥ 40%, the combined BETAMI-DANBLOCK trial showed that beta-blockers reduced the risk of all-cause mortality or major adverse cardiovascular events. This study evaluated the representativeness of the trial.